Check One: Follow the Listing Back to a Sponsor and a Site
A registry-style entry, a clinic flyer, and a sponsored ad are different products. The first usually names a sponsor and a site; the second often names only a department; the third may not name a trial at all. A flyer with no trial name is not a dead end — it is simply a listing that has not yet told you who is behind it. Before anything else, find the sponsor organization and the physical site where visits would happen, then ask who answers the phone: site staff, a hospital switchboard, or an outside recruiter paid to fill slots. What good looks like is a named sponsor, a named site with a street address, and a contact route you can trace back to that site. What to ask: "Who sponsors this study, which site would I attend, and are you employed by that site?"
Check Two: Treat the Stage Label as a Question You Will Ask
Listings often lead with a phase number. This article does not define those phases, because the definitions should come from the registry record or the study team rather than from a summary. What you can do is stop reading the label as a benefit claim. A stage describes what a study is designed to learn, not what any one participant will receive. If a listing converts a stage label into a promise of personal benefit, that is a claim the label cannot support, and it belongs on your list of questions rather than your list of reasons to call. What to ask: "What is this study designed to answer, and what would I be asked to do differently from my current care?"
Check Three: Convert the Schedule Into Hours and Travel
Eligibility wording reads like exclusion because much of it is: it tells you what the protocol requires and what removes a person from consideration, so read it as two lists rather than one wall of text. Then move to the schedule of assessments and turn it into a burden estimate — visits in the first months, how long each lasts, fasting labs, travel, diaries, phone check-ins, and whether any visit can happen locally. If you are screening for a parent or partner, put their visit and transport commitments into that estimate too. Burden figures must come from the protocol in front of you, never from what you have heard about trials in general. What to ask: "How many visits in the first three months, how long is each, and what happens at each one?"
Check Four: Ask Who Pays, in Writing
Cost language is where listings quietly overstate most often. Do not assume trial care is free, and do not assume payment is standard; neither is something this article can promise, and coverage depends on the specific protocol plus your plan. Separate three categories instead: items the study covers, items routed to your insurer, and any reimbursement described in the documents. Because terms vary by trial, site, insurer, and state, get the answer in writing before a screening visit. What to ask: "Which costs does the study cover, which go to my insurance, and can you send that in writing?"
Check Five: Consent Has Stages, and Your Usual Care Continues
A phone call is not a yes, and a screening visit is not a signature. Consent is a stepped conversation that should pause for questions at each stage, which is why asking basic questions late is still normal rather than a sign of doubt. Ask what information the study collects, who can see it, and whether the team will coordinate with the clinician who manages your diabetes. Keep that clinician in the loop: this article cannot tell you whether trial participation substitutes for routine care, and only the study team can describe the protocol's actual schedule. What to ask: "What do you collect about me, who sees it, and will you tell my regular clinician what happens here?"
Wording That Should Slow You Down
Some phrases signal a promise the listing cannot keep: guaranteed benefit, a cure or reversal, "free treatment for everyone," "no placebo, ever," a specific payment amount quoted before eligibility is confirmed, "spots closing today," or a claim of zero risk.
Google's publisher policies prohibit misleading statements, including misrepresenting a content's purpose or implying an affiliation or endorsement that does not exist, and they treat concrete promises outside a publisher's control as egregious violations. Those rules govern advertising rather than your judgment of any one clinic, so use such phrasing as an information gap to ask about, not as proof of bad intent. Related rules also bar promoting unapproved drugs and supplements and facilitating online prescription-drug sales — a reason for caution when a listing advertises a product alongside a trial. Health information is likewise treated as sensitive under Google's privacy-related rules, which bar using it to target ads or build audience lists.
A Script for the First Call
Read these aloud:
- Who sponsors the study, and which site would I attend?
- What is the study designed to learn?
- How many visits in the first three months, and how long are they?
- Which costs does the study cover, and what goes to my insurance?
- What do you collect about me, and who sees it?
- Who is my contact if I decide not to continue the conversation?
What This Screen Cannot Decide
It cannot tell you whether you are eligible, what a trial would cost you, or whether one study is safer than another. Eligibility is protocol-specific; costs depend on the protocol, your plan, and your state; and nothing here ranks studies or predicts benefit. Treat this as a filter for which listing deserves a call, and take the medical decisions to your own clinician and the study team. No affiliation with, or endorsement by, any sponsor, site, registry, recruiter, or Google is claimed or implied.
研究の知恵